Literature DB >> 27401449

Statistical Report of Central Nervous System Tumors Histologically Diagnosed in the Sichuan Province of China from 2008 to 2013: A West China Glioma Center Report.

Xiang Wang1, Jin-Xiu Chen2, Qiao Zhou3, Yan-Hui Liu3, Qing Mao3, Chao You3, Ni Chen3, Li Xiong4, Jie Duan5, Liang Liu6.   

Abstract

BACKGROUND: Sichuan is a province in the west of China with a population of 81.4 million. This is the first statistical report of central nervous system (CNS) tumors surgically treated and histologically diagnosed in a large Chinese population.
METHODS: All the patient data were obtained from 86 medical facilities, which covered the Sichuan province population. Data from patients who underwent surgery between 2008 and 2013 and corresponding histology samples were re-reviewed in the major pathology centers. All the CNS tumors were categorized according to International Classification of Diseases (ICD)-10 and ICD-O-3 classifications and reviewed manually. The tumor distribution was analyzed and stratified by gender, age, race, and tumor sites. Tumors in some ethnic minorities, such as the Tibetan people, also were analyzed.
RESULTS: The final analytic dataset included 35,496 records. The top four histologic tumors were meningioma (28.51 %), pituitary adenoma (15.00 %), nerve sheath (13.77 %), and glioblastoma (11.82 %). There was a dramatically high incidence of malignant tumor in males. The median age at diagnosis ranged from 13 years (pineal region tumors) to 56 years (metastatic brain tumors). Most of the tumors in the insular lobe or cerebellum were low grade, whereas those in the thalamus or basal ganglia were likely to be high grade. The incidence of malignant tumors or high-grade gliomas in the Tibetans was significantly lower than in the Chinese Han population.
CONCLUSION: This report is a preliminary statistical analysis of brain and spinal tumors in a large Chinese population and may serve as a useful resource for clinicians, researchers, and patients' families.

Entities:  

Mesh:

Year:  2016        PMID: 27401449     DOI: 10.1245/s10434-016-5410-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.

Authors:  Hao Yu; Huiling Lou; Tianyu Zou; Xianlong Wang; Shanshan Jiang; Zhongqing Huang; Yongxing Du; Chunxiu Jiang; Ling Ma; Jianbin Zhu; Wen He; Qihong Rui; Jianyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2017-05-22       Impact factor: 5.315

2.  MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating β-catenin and causing activation of FOXO3a.

Authors:  Ming Lu; Yong Wang; Shizhen Zhou; Jun Xu; Jing Li; Rongjie Tao; Yufang Zhu
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

3.  Future Strategies on Glioma Research: From Big Data to the Clinic.

Authors:  Hang Cao; Feiyifan Wang; Xue-Jun Li
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-08-07       Impact factor: 7.691

4.  Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system.

Authors:  Haihui Jiang; Yong Cui; Junmei Wang; Song Lin
Journal:  Oncotarget       Date:  2017-03-21

5.  Central nervous system tumours profile at a referral center in the Brazilian Amazon region, 1997-2014.

Authors:  Luis Eduardo Werneck de Carvalho; Jonathan Souza Sarraf; Aluízio Augusto Pereira Semblano; Matheus Acácio Moreira; Manuela Nascimento de Lemos; Vanessa Jóia de Mello; Moisés Hamoy; Mario Hermes Nazareth Junior; Fernando Mendes Paschoal Junior; Fernando Adami
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

6.  Silencing Of MAGI1 Promotes The Proliferation And Inhibits Apoptosis Of Glioma Cells Via The Wnt/β-Catenin And PTEN/AKT Signaling Pathways.

Authors:  Yongzhi Lu; Wei Sun; Liang Zhang; Junyao Li
Journal:  Onco Targets Ther       Date:  2019-11-13       Impact factor: 4.147

7.  Gallic acid-gold nanoparticles enhance radiation-induced cell death of human glioma U251 cells.

Authors:  Zhou Jing; Minghe Li; Hongyuan Wang; Zhuo Yang; Shaolong Zhou; Jian Ma; Enping Meng; Hengwei Zhang; Wulong Liang; Weihua Hu; Xinjun Wang; Xudong Fu
Journal:  IUBMB Life       Date:  2020-12-28       Impact factor: 3.885

8.  HAX1 maintains the glioma progression in hypoxia through promoting mitochondrial fission.

Authors:  Jinghui Lin; Yang Wang; Zhiqing Lin
Journal:  J Cell Mol Med       Date:  2021-11-10       Impact factor: 5.310

9.  Pro-apoptotic effect of TRAIL-transfected endothelial progenitor cells on glioma cells.

Authors:  Xin Deng; Wen Zhao; Laijun Song; Wei Ying; Xinbin Guo
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

10.  Downregulation of S100 calcium binding protein A12 inhibits the growth of glioma cells.

Authors:  Chunhe Lu; Jia Liu; Mingze Yao; Lun Li; Guangyu Li
Journal:  BMC Cancer       Date:  2020-03-30       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.